NEW YORK (GenomeWeb) – Aviva Systems Biology said today it has acquired protein tools firm GenWay Biotech.

In a statement, Aviva CEO Peter Jiang described the purchase as part of his company's larger plan to "become a leading provider of proteomic solutions," and cited GenWay's experience and assets in protein, antibody, and ELISA production for both the research and clinical markets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.